LCI Corporation at AAPS PharmSci 360 2026: Pharmaceutical Processing Solutions at Booth 1028
Discover LCI Corporation’s pharmaceutical processing solutions at AAPS PharmSci 360 2026, Booth 1028 in New Orleans. Explore continuous wet granulation, drug pelleting, extrusion and spheronization, powder feeding, drying, evaporation, and laboratory testing services designed to support pharmaceutical process development, scale-up, and commercial manufacturing.
AAPS PharmSci 360 2026 takes place October 25 to 28, 2026, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. LCI Corporation will be at Booth 1028, connecting with pharmaceutical scientists, formulation experts, process engineers, and manufacturing professionals working across drug development and production.
From continuous wet granulation and drug pelleting to extrusion, spheronization, feeding, drying, and evaporation, LCI provides process technologies and engineering support that help pharmaceutical manufacturers move from laboratory development toward scalable production.
LCI Corporation at AAPS PharmSci 360 2026
LCI Corporation, based in Charlotte, North Carolina, provides process technology, equipment, and engineering support for powder processing and evaporation applications. At Booth 1028, attendees can speak directly with LCI's process engineering team about equipment for extrusion and spheronization, continuous wet granulation, pelleting, feeding, drying, and evaporation, as well as the laboratory and pilot-scale testing services LCI uses to validate process solutions before scale-up.
Visitors to Booth 1028 can expect a technical conversation rather than a sales pitch. LCI's team works from real process data: bench and pilot trial results, throughput requirements, particle characteristics, and scale-up targets.
Connecting Pharmaceutical Process Technology with Drug Development
Moving a pharmaceutical formulation from bench to commercial scale depends on process technology decisions made well before a product reaches manufacturing. LCI Corporation's equipment portfolio addresses several of the unit operations that pharmaceutical development teams work through during that transition.
| Unit Operation | LCI Capability | Pharmaceutical Relevance |
|---|---|---|
| Granulation | Continuous wet granulation systems | Supports consistent particle characteristics and continuous processing |
| Extrusion & spheronization | Extruders, granulators and marumerizer spheronizers | Produces uniform pellets for multiparticulate dosage forms |
| Drug pelleting | Continuous drug pelleting systems | Designed for continuous pharmaceutical pellet production |
| Feeding | Circle Feeder | Consistent feeding of powders. First in, first out. No bridging or ratholing |
| Drying & evaporation | Thin film, wiped film and short path evaporators | Supports concentration, solvent recovery and protects heat sensitive molecules |
| Testing & scale-up | LCI Test Center | Enables process testing and equipment validation before scale-up |
| System integration | Process engineering and fabrication | Supports equipment integration from design through commissioning |
For pharmaceutical manufacturers, the transition from formulation development to commercial production brings its own process challenges. Equipment selection, process parameters, scale-up, and system integration can all influence how successfully a formulation moves into manufacturing. LCI combines process engineering, testing, and equipment expertise to support this transition.
What Can You Discuss with LCI at Booth 1028?
Visitors can speak with LCI's process engineering team about specific development and manufacturing challenges, including:
- Continuous drug pelleting: Process and equipment considerations for pharmaceutical pellet production
- Continuous wet granulation: Opportunities to improve consistency and throughput compared with batch processing
- Extrusion and spheronization: Pellet production for multiparticulate dosage forms
- Feeding: Circle feeders keep feed consistent. No bridging or ratholing.
- Drying and evaporation: Concentration, solvent recovery, and drying applications
- Testing and scale-up: Using laboratory and pilot-scale trials to evaluate process parameters before full-scale investment
Why Work with LCI?
- Test before you scale. Bench and pilot-scale testing helps evaluate equipment and process parameters before committing to full-scale systems.
- From process development to commissioning. LCI combines testing, process engineering, fabrication, and commissioning to support projects across multiple stages.
- Expertise in continuous processing. Continuous wet granulation and drug pelleting technologies support manufacturers evaluating alternatives to traditional batch operations.
- Support beyond installation. Parts, field service, troubleshooting, and equipment refurbishment provide ongoing support throughout the equipment lifecycle.
Who Should Visit LCI at AAPS PharmSci 360?
- Pharmaceutical and formulation scientists
- Process development scientists and engineers
- Manufacturing and operations professionals
- R&D leaders evaluating continuous processing
- CDMOs and contract manufacturers
Meet LCI Corporation at Booth 1028
Planning your next pharmaceutical process development or scale-up project? Visit LCI Corporation at Booth 1028 during AAPS PharmSci 360 2026. Talk with LCI's process experts about your requirements for granulation, pelleting, extrusion, spheronization, feeding, drying, evaporation, testing, and scale-up.
Event details: AAPS PharmSci 360 2026, October 25 to 28, 2026, Ernest N. Morial Convention Center, New Orleans, Louisiana, Booth 1028.
FAQs
AAPS PharmSci 360 2026 is the American Association of Pharmaceutical Scientists' flagship annual meeting, bringing together pharmaceutical scientists, researchers, and industry professionals to discuss advances across drug discovery, formulation, manufacturing, and delivery. The event includes scientific sessions, poster presentations, and an exhibit hall.
AAPS PharmSci 360 2026 runs October 25 to 28, 2026.
The event takes place at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
LCI Corporation will be located at Booth 1028 throughout AAPS PharmSci 360 2026.
LCI's relevant technologies include extrusion and spheronization systems, continuous drug pelleting equipment, continuous wet granulation systems, thin film and short path evaporators, and laboratory and pilot-scale testing through its Test Center, supporting process development from bench scale through commercial manufacturing.
Pharmaceutical scientists, formulation scientists, process development and manufacturing engineers, R&D leaders, and CDMO or contract manufacturing professionals working on powder processing, granulation, pelleting, drying, or evaporation challenges should visit Booth 1028.
LCI's process engineering, test center, and system integration services support process development and equipment sourcing for pharmaceutical manufacturers and CDMOs evaluating or scaling up powder processing and evaporation equipment.